key: cord-0873422-moj7zp7x
authors: Butt, Waleed; Dhillon, Permesh Singh; Lenthall, Robert; Malik, Luqman; Izzath, Wazim; Krishnan, Kailash; George, Bindu; Pointon, Kate
title: Left Atrial Enlargement on Non-Gated CT Is Associated with Large Vessel Occlusion in Acute Ischaemic Stroke
date: 2021-09-22
journal: Cerebrovasc Dis Extra
DOI: 10.1159/000519121
sha: 7e01f80230ebd1c0d2f83d729591eba2642ac082
doc_id: 873422
cord_uid: moj7zp7x

BACKGROUND: Recent reports have suggested that atrial fibrillation (AF) is more prevalent in the large vessel occlusion (LVO) subgroup of acute ischaemic stroke patients. Given the association between left atrial enlargement (LAE) and AF, we sought to evaluate the feasibility of assessing LAE on non-gated CT and its association with LVO in the hyperacute stroke setting. METHODS: We analysed our prospectively collected database that included all stroke patients referred for consideration of endovascular treatment between April 14, 2020, and May 21, 2020. During this period, a CT chest was included in our regional stroke protocol to aid triage of patients suspected for COVID-19 from which cardiac measurements were obtained. Patients were dichotomized into LVO and no-LVO groups, and LA measurements were trichotomized into normal, borderline, and enlarged. Univariate analyses were performed between groups. RESULTS: Of the included 38 patients, 21 were categorized as LVO and 17 as no LVO. There was a statistically significant association between LAE and LVO (p = 0.028). No significant difference was demonstrated between groups for the baseline AF and other clinical characteristics, except for baseline NIHSS (p = 0.0005). There was excellent inter- and intra-rater reliability (ICC = 0.969) for LA measurements. CONCLUSION: Our study provides preliminary data to suggest LAE is more prevalent in the LVO stroke subgroup at presentation and can be reliably assessed on non-gated CT in the hyperacute setting. These findings have potential implications for stratifying secondary management and may prompt a more rigorous pursuit of occult AF or other cardiac causes of stroke.

Large vessel occlusion (LVO) of the proximal intracra nial circulation may account for >30% of all acute is chaemic stroke (AIS) presentations and without treat ment is associated with significantly worse outcomes com pared to nonLVO AIS [1, 2] . The aetiology of LVO can be due to (1) in situ thrombosis of the primary arterial site secondary to underlying atherosclerosis, (2) erosclerotic plaque or dissection, (3) cardiac embolism, or (4) cryptogenic causes of vessel occlusion. Cardioembo lism accounts for an increasing share of AIS with the most common risk factor being atrial fibrillation (AF) [3] .

Recent studies have suggested that AF is more com mon in the LVO subgroup stroke population [4] [5] [6] . Giv en the association between left atrial enlargement (LAE) and AF [7, 8] , we hypothesized LAE may be associated with LVO and thereby indicate potential stroke aetiology and direct secondary management. Cardiac imaging is not routinely performed in the hyperacute stroke setting, and there is variation in patient selection for subsequent echocardiographic assessment, which is limited in avail ability and is operator dependent [9] .

The mandate to detect coronavirus disease 2019 (CO VID19) led to the inclusion of thoracic CT in our re gional stroke imaging protocol to aid risk stratification for patients and clinical staff. Acquisition of thoracic CT also provided a basic cardiac imaging dataset, acquired at presentation in ischaemic stroke patients deemed clini cally eligible for EVT by our referring centres. Herein, we sought to evaluate LAE on nonECGgated CT in patients with and without angiographic evidence of LVO in this cohort.

This study was registered and approved by our institution's au dit committee, and individual patient consent was waived. We re viewed our prospectively collated database of all stroke referrals considered for EVT between April 14, 2020, and May 21, 2020. Additional clinical variables were obtained from the electronic hospital records.

In our standard regional imaging algorithm, all acute stroke referrals presenting with a suspected LVO within 24 h of symptom onset undergo an unenhanced CT head and dualphase CT angio gram from the aortic arch to the skull vertex. As previously de scribed in our recent publication [10] , our modified protocol in cluded the addition of a noncontrast or delayed postcontrast chest CT for all patients except those who had a confirmed COVID19 status. Data collated included patient demographics, presence of LVO, tandem carotid or vertebral lesion, LA measurement, AF, hypertension, diabetes mellitus, cardiac failure, previous stroke or transient ischaemic attack, baseline National Institutes of Health Stroke Scale (NIHSS), COVID19 status, and anticoagulant drug status at presentation.

NonECGgated chest CT images were obtained on a Somatom Definition AS or AS Plus, 64 or 128slice multidetector CT system (Siemens Healthineers, Camberley, UK) at our institution. The scan range was from the lung apices to the diaphragms immedi ately following acquisition of the dualphase CT angiogram from the aortic arch to the skull vertex. The following acquisition pa rameters were used: tube voltage of 120 kV, tube current of 70 mA, 0.5s helical rotation time, and 1.2 helical pitch. The reconstructed axial CT slice thickness was 1 mm, and further sections were re constructed in the axial, coronal, and sagittal planes of 2mm sec tion thickness at 2mm increments. The effective radiation dose calculated from the total dose length product and additional time incurred from the completion of the dualphase CT angiogram to the completion of CT chest were obtained from the radiological information system. There were variations of the scanner models and acquisition parameters across the regional hospitals.

Craniocervical imaging was reviewed by a neuroradiologist whilst the cardiac findings were analysed and recorded by 2 inde pendent cardiothoracic radiologists who were blinded to the neu rovascular findings. LVO was defined by occlusion of the internal cerebral artery, M1/M2 middle cerebral artery, or the basilar ar tery. The LA measurement was taken in the anteriorposterior di rection on nonreformatted axial images at the level of the aortic root (Fig. 1) . LA measurement was trichotomized into normal (<43 mm), borderline (43-47 mm), and enlarged (>47 mm).

Standard data and statistical analysis (including t test, Mann Whitney U test, and χ 2 or Fisher's exact test) was carried out using GraphPad Prism (GraphPad Software, Inc.). Statistical signifi cance was set at p < 0.05. Comparisons were made using the LA measurements as a continuous variable and LAE classed as a cat egorical variable. Univariate analyses were performed between groups. Intraclass correlation coefficients (ICCs) were calculated as a measure of interrater (2way random effect, absolute agree ment) and intrarater (2way mixed effect, absolute agreement) reliability between 2 cardiothoracic radiologists using the LA mea 

Since the implementation of the revised imaging pro tocol during the study period, we received 49 referrals for consideration of EVT. Thoracic CT imaging was not per formed in 11 patients, and hence these patients were ex cluded from the final analysis. Of the included 38 pa tients, the mean age was 72.9 ± 12.6 (SD) years, and there were 19 males and 19 females. The mean additional time incurred for the chest CT was 184 ± 65.5 (SD) s, range of 45-337 s. The average added effective radiation dose from the extension of the chest CT was 2.47 ± 1.03 (SD) mSv. No patient was identified to have a tandem lesion.

The patient characteristics, dichotomized into 2 groups (21 LVO vs. 17 no LVO), are summarized in (Ta ble 1). There was a statistically significant association be tween LA size categories and the presence of LVO (p = 0.028), which is presented in Figure 2 

Our results indicate an association between LAE dem onstrated on nonECGgated CT and LVO. The implica tion of the increased frequency of LVO in the LAE group in comparison with the borderline group remains un clear. However, it is plausible that only "moderate" or "se vere" LAE is associated with LVO. This would be consis tent with previous findings in which the degree of LAE is related to the cumulative risk of adverse cardiovascular outcomes including heart failure, AF, myocardial infarc tion, and stroke [11] .

Chang et al. [12] investigated cardiac markers for LVO and reported an association between LVO and LA diam eter on transthoracic echocardiography (TTE); however, an association with LAE could not be gleaned from their study. Furthermore, whilst TTE remains the most widely used modality to assess LA size, it is operator dependent, time intensive, and may have technical limitations [13] . In practice, TTE is not always rapidly or consistently uti lized, which in turn may cause a delay to diagnosis.

Modern multidetector CT that is widely available has capabilities that enable rapid image acquisition to miti gate cardiac motion artefacts with enhanced temporal and spatial resolution. It has been shown that using a 43 mm cutoff on nonECGgated CT for the greatest anteri orposterior LA diameter on axial nonreformatted im ages provides 60.5% specificity and 85% sensitivity when compared with echocardiographic dimensions [14] . When using a threshold of 45 mm, the specificity has been reported as 94% [15] . Given the thresholddependent tradeoff between sensitivity and specificity, we took the view that using a single cutoff value to dichotomize LAE would limit accuracy and fail to account for errors in measurement due to noncontrast acquisition and inter observer variation which in turn may mask a true asso ciation.

There are emerging prospective data to suggest that in the cryptogenic stroke population, LVO is independently associated with covert paroxysmal AF [16] . There is also a higher incidence of cardioembolic aetiology in LVO re currence [17] . Although risk factors for ischaemic stroke are well known, the cause remains undefined in 25-39% of patients who experience an acute event, even with full diagnostic evaluation [18] . In the recent secondary analy sis of the NAVIGATE ESUS trial, it was shown that in patients with embolic stroke of undetermined source and LAE, treatment with rivaroxaban resulted in a 74% reduc tion in stroke recurrence [19] . Our findings therefore have potential implications as the increased presence of LAE in the LVO subgroup may prompt a more rigorous pursuit of occult AF or other cardiac causes of stroke and aid secondary prevention stratification in future trials as sessing LAE as a treatment target. An association between AF and LVO was not revealed in our study, and this may have been due to underinvestigation or sample size.

Imaging algorithms for ischaemic stroke do not rou tinely include cardiac imaging in the hyperacute period, although the feasibility has been demonstrated without incurring a time penalty in a "tripleruleout" protocol [20] and in the present study. Furthermore, the mean ra diation dose of 2.47 mSv for the chest CT we report falls below the average radiation dose per person/annum in the UK. LA measurements proved to be simple, quick, and reproducible, demonstrated by the excellent intra and interrater agreement.

Although the baseline data were prospectively collat ed, our study is limited by its singlecentre retrospective review and sample size. Second, our population may have excluded patients ineligible for EVT on clinical grounds (modified Rankin score >2 and NIHSS < 5), which limits the generalizability of our findings. Third, it is not pos sible to establish causality as not all clinical factors, in cluding body surface area, that influence LA size were analysed. Last, the disproportionate number of patients with LVO who were excluded due to the absence of tho racic imaging (10 out of 11) may introduce a sampling bias.

Our study of a patient cohort presenting during the COVID19 pandemic demonstrates feasibility of the in clusion of nonECGgated cardiac CT imaging during the immediate workup of acute stroke presentation and pro vides preliminary evidence that LAE may be associated with LVO. The presence of LAE in LVO may prompt a more thorough workup and management of an underly

Ischemic strokes due to largevessel occlusions contrib ute disproportionately to strokerelated de pendence and death: a review

Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10year systematic re view of the literature

Agespecific in cidence, outcome, cost, and projected future burden of atrial fibrillationrelated embolic vascular events: a populationbased study

Specific factors to predict largevessel occlusion in acute stroke patients

Effect of known atrial fibrillation and anticoagulation status on the prehospital identification of large vessel oc clusion

How much does atrial fibrillation contribute to large vessel occlu sions? (P1.3049)

Atrial enlargement as a consequence of atrial fibril lation. A prospective echocardiographic study

Association between atri al fibrillation, atrial enlargement, and left ven tricular geometric remodeling

Cardiac work up of ischemic stroke: can we improve our di agnostic yield?

Regional mechanical thrombectomy imaging protocol in patients presenting with acute ischaemic stroke during the COVID19 pandemic

Left atrial size: physiologic determinants and clinical applications

Cardiac biomarkers pre dict large vessel occlusion in patients with ischemic stroke

Transthoracic echocardiography: pitfalls and limitations as delineated at cardiac CT and MR imaging

Left atrial transverse diameter on computed tomography angiog raphy can accurately diagnose left atrial en largement in patients with atrial fibrillation

Accuracy of nonECGgated com puted tomography angiography of the chest in assessment of leftsided cardiac chamber enlargement

Large vessel occlusion is independently associated with atrial fibrillation detection

Repeated mechanical thrombectomy in shortterm large vessel occlusion recurrence: multi center study and systematic review of the lit erature

Underlying pathology of stroke of unknown cause (cryptogenic stroke)

Recur rent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibril lation: secondary analysis of the NAVIGATE ESUS randomized clinical trial

The triple ruleout for acute ischemic stroke: imaging the brain, carotid arteries, aorta, and heart

The authors have no conflicts of interest to declare.

The authors received no funding for this study.

W.B., P.S.D., and R.L. contributed to study conception and de sign. W.B., P.S.D., L.M., B.G., and K.P. contributed to acquisition of the data. W.B., P.S.D., B.G., R.L., and K.P. contributed to analy sis and interpretation of the data. K.K., W.I., L.M., and R.L. con tributed to critical revision of the manuscript. R.L. and K.P. con tributed to study supervision.

All data generated or analysed during this study are included in this article. Further enquiries can be directed to the correspond ing author.